NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

Going back to the question of announcing the full enrollment status. I still don't see how this would assist anyone in modeling. They didn't announce when the 1st IA occurred, they don't have to announce when the 2nd IA occurs. Everyone is expecting top-line results by the end of next year at the latest.

Because of the wide variability in enrollment pace over the years, I just don't see how this extra piece of information would provide a missing link in modeling the length of PFS or anything related to OS. Maybe I'm missing something. Also, it seems in my limited experience that companies commonly announce full enrollment status.. It makes more sense to me that the trial hasn't 'officially' reached full enrollment (some of the pipeline patients are still somewhere between screening and first treatment).